Business / Finance

RSS

Covalon reports net loss of $1,207,559 for third quarter 2011

Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update. "We are very pleased that Covalon continues to make excellent progress in meeting its objectives.

29 Aug 2011

Affinium closes $15 million financing round

Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.

29 Aug 2011

Health Robotics first half gross revenues increase 42% to $9.4 million

Health Robotics today announced 1H2011 financial results, delivering record levels of revenues, gross margins and net earnings for a six-month period. Gross Revenues reached $9.4 million (€6.5M) and Gross Margins were $7.3 million (€5M), respectively 42% and 72% increases over-year-ago period; both increases were directly linked to the significantly improved performance resulting from Health Robotics' greater dependence on its own European and American based staff, replacing its prior, non-functioning indirect distribution and service channels.

29 Aug 2011

European infusion therapy device market to reach €533 million by 2017: New report

According to a new report by iData Research, the leading global authority in medical device market research, the European infusion therapy device market, which includes needleless connectors, infusion pumps and intravenous (IV) sets, was valued at an estimated €443 million in 2010.

29 Aug 2011

SQI Diagnostics third quarter net loss increases to $2,691,000

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.

29 Aug 2011

Infrared Systems completes several internal projects, discusses corporate strategies

Infrared Systems International announces the completion of several internal projects and discusses corporate strategies for continued success.

29 Aug 2011

QIAGEN acquires Cellestis

QIAGEN N.V. today announced that its acquisition of all the ordinary shares in Cellestis Limited by a way of a scheme of arrangement has been implemented.

From QIAGEN Manchester Limited 29 Aug 2011

QLI, author of 'The Steve Jobs Way' sign licensing agreement for new training program

Quantum Learning, Inc. (QLI), a research-based provider of advanced sales and marketing training programs, and Jay Elliot, author of the book "The Steve Jobs Way" http://www.thestevejobsway.com, jointly announced today a licensing agreement.

29 Aug 2011

Triad Senior Living announces acquisition of University Village retirement community

Triad Senior Living, Inc., a Dallas based senior housing provider with offices now in Tulsa, announced the successful acquisition of the University Village retirement community in Tulsa.

29 Aug 2011

Victhom second quarter revenues up 30.4%

Victhom Human Bionics Inc. today reported its second quarter 2011 financial results.

26 Aug 2011

BioSpec Global Solutions commences talks with U.K., Chinese distributors for TOGS product lines

ICBS Ltd., announced today that partner BioSpec Global Solutions Inc. has opened talks with a U.K. , and Chinese distributors for the TOGS product lines.

26 Aug 2011

Varian enters accelerated share repurchase agreement

Varian Medical Systems today announced that it has entered into an agreement with Bank of America, N.A. to repurchase $250 million of its common stock under an accelerated share repurchase program. Concurrently, the company amended its revolving credit facility with Bank of America, N.A. to increase its borrowing capacity from $225 million to $300 million.

26 Aug 2011

BioPhausia to sell generics business to Bluefish Pharmaceuticals

Medivir AB, is an expanding, research-based specialty pharmaceutical company focusing on infectious diseases. Medivir reports that on 25 August, BioPhausia AB reached an agreement to sell its generics business in the form of subsidiary BMM Pharma AB to Bluefish Pharmaceuticals AB for SEK 26 m plus the value of inventories, some SEK 12 m.

26 Aug 2011

Essilor introduces first high performance anti-fogging lenses

Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.

26 Aug 2011

MDxHealth first half 2011 commercial revenues increase 19%

MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.

25 Aug 2011

Allenex net sales increase 8.2% to SEK 44.9 million for January - June, 2011

Allenex AB: Net sales for the first six months were SEK 44.9 million (41.5), an increase of 8.2%.

25 Aug 2011

Baxter enters definitive agreement to acquire Baxa

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire Baxa Corporation, a privately held company based in Englewood, Colo., with additional operations in Florida and the United Kingdom.

From Baxter International Inc. 25 Aug 2011

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

25 Aug 2011

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the first half year of 2011.

25 Aug 2011

Healthways to acquire Navvis

Ben R. Leedle, Jr., president and CEO of Healthways, announced that the Company has signed a definitive agreement to acquire Navvis & Company, a St. Louis-based firm providing strategic counsel and change management services both to enable its healthcare system clients to become future-ready clinical enterprises and to align the incentives for all stakeholders.

25 Aug 2011